Basic helix-loop-helix (bHLH) transcription factors have been shown to be essential for speci®cation of various cell types. Here, we describe a novel bHLH family consisting of three members, two of which (Olig1, Olig2) are expressed in a nervous tissue-speci®c manner, whereas the third, Olig3 is found mainly in non-neural tissues. Olig1 and Olig2, which recently have been implicated in oligodendrogenesis, are expressed in the region of the ventral ventricular zone of late embryonic spinal cord where oligodendrocyte progenitors appear. In the embryonic brain, the Olig2 expression domain is broader than that of Olig1 and does not overlap with an oligodendrocyte progenitor marker, CNP. Furthermore, Olig2 is expressed in most cells in the ventral half of the early embryonic spinal cord, which do not yet express an early neuronal marker TuJ1. These results indicate that Olig2 expression is not limited to the oligodendrocyte lineage but includes immature neuronal progenitors and multipotential neuron/glia progenitors as well as embryonic olfactory neurons. q
Results
In order to understand the molecular mechanisms underlying cell type speci®c differentiation, we attempted to identify new bHLH gene(s) by database search and found three highly related genes. During the course of our investigation, two were reported independently by other groups (Lu et al., 2000; Zhou et al., 2000; Wang et al., 2000) . According to the nomenclatures proposed, these are designated as Olig1 and Olig2. We originally identi®ed Olig1 and Olig2 from human genomic sequences within a single bacterial arti®cial chromosome (BAC) clone derived from 21q22.1 (GenBank AP000041). Olig3 was found in a BAC clone derived from human 6q24 (GenBank AL023580). Since Olig1 and Olig2 sequences were found in several human ESTs derived from oligodendroglioma or glioblastoma, we speculated a relationship between these genes and glia. Human Olig2 was previously identi®ed as RACK17 by Kuroda et al. (GenBank Q13516) . No EST clone has been found for Olig3.
The predicted amino acid sequences of the Olig genes represented highly related class B bHLH factors (Fig.  1A,B) . A characteristic of this family is substitution of a conserved phenylalanine (or leucine in NeuroD family) residue by methionine as indicated in Fig. 1A . No signi®cant homology was found among the Olig genes outside the bHLH domains, but the presence of particular amino acid clusters in their N-or C-terminal regions is indicated in Fig.  1C . Northern blot analysis showed that Olig1 (2.2 kb) and Olig2 (2.4 kb) transcripts are brain-speci®c, whereas the 3.0 kb Olig3 transcript was weakly detected only in skeletal muscle (Fig. 1D) . In multiple tissue array dot blot analysis, strong expression of Olig1 and Olig2 was observed over the entire adult human brain, and weak but above background expression of Olig3 was detected in skeletal muscle, testis and submaxillary gland in mouse tissues (data not shown). One Olig3 clone from mouse E9.0 rhombomere was found (Murre et al., 1989) . f indicates hydrophobic amino acids. The methionine residue in helix I unique to Olig family is indicated by an arrow. Sources of sequences are: Olig1 (GenBank AB038696), Olig2 (GenBank AB038697), Olig3 (GenBank AB038698), NeuroD (Lee et al., 1995) , neurogenin (Ma et al., 1996) , MATH1 (Akazawa et al., 1995) , M-Twist (Wolf et al., 1991) , paraxis (Burgess et al., 1995) , eHAND , MyoD (Davis et al., 1987) , myogenin (Edmondson and Olson, 1989) . All sequences are derived from mouse. (B) Phylogenetic tree of Olig genes and other bHLH factors. Olig1, Olig2 and Olig3 form a subfamily distinct from other bHLH transcription factors. Note that c-myc is a class C bHLH-leucine zipper protein and E12 is a class A protein.
The tree was drawn by Higgins method using DNASIS (Hitachi software engineering). Sources of sequences are mouse c-myc (Neuberger and Calabi, 1983) , human E12 (Nourse et al., 1990) in the BodyMap database (Hishiki et al., 2000) . The chromosomal localizations of mouse Olig family genes were determined by intersubspeci®c backcross mapping (Fig.  1E ). Olig1 and Olig2 are closely linked on chromosome 16 at the syntenic region to human 21q22. Olig3 localizes to chromosome 10, syntenic to human 6q24.
To identify the cell type(s) expressing Olig genes, in situ hybridization (ISH) was performed on mouse sections. Preliminary ISH analysis with Olig3 antisense probe in various tissues gave rise to no signi®cant staining, presumably due to its weak expression. In the postnatal brain, Olig1-and Olig2-expressing cells were present preferentially in white matter such as corpus callosum and cerebellar medulla (P14 in Fig. 2A ,B; P7, P3, P1 not shown), and spread out as they mature (data not shown). Although Olig1-expressing cells were more abundant than Olig2-expressing cells at this stage, we believe coexpression occurs in a signi®cant portion of cells since overlapping signals were detected in adjacent sections (data not shown). Positive cells characteristically had small nuclei and scarce cytoplasm which together with their distribution patterns suggested a glial identity. Among the three major glial cell types (astrocyte, oligodendrocyte and microglia) in the brain, they seemed to correspond to the oligodendrocyte lineage for the following reasons. First, the distribution pattern of Olig1/2-expressing cells during postnatal development resembled that of GD3/carbonic anhydrase II (CA II) positive oligodendrocyte progenitors (LeVine and Goldman, 1988) . Second, Olig1/2 transcripts did not co-localize with glial ®brillary acidic protein (GFAP), a marker for mature astrocytes (Fig. 2C,D) . Third, there were many Olig1/2-expressing cells in the optic nerve, where astrocyte and oligodendrocyte predominate (data not shown). Further evidence was provided from Olig1/2 expression in the embryonic spinal cord, the most intensively studied region of oligodendrogenesis. Spinal cord oligodendrocyte progenitors are ®rst identi®ed by their PDGFRa and CNP expression, in a very restricted region of the ventral ventricular zone in E12.5 mouse or E14.0 rat embryos (Yu et al., 1994; Ono et al., 1995; Hall et al., 1996) . In the E14.5 mouse spinal cord, Olig1/2 are expressed in CNP-positive oligodendrocyte progenitors of the ventral ventricular zone but not dorsal root ganglia Schwann cells (Fig. 2E±G) . In addition to the ventral ventricular zone, Olig1/2-expressing cells are also observed scattered within the mantle zone, likely corresponding to oligodendrocyte progenitors migrating out from their site of origin (Fig. 2E,F) . The timing of appearance and distribution pattern of Olig1/2-expressing cells in the mantle zone resemble that of PDGFRa-expressing oligodendrocyte progenitors (Fruttiger et al., 1999) . Interestingly, their expression can be traced back to a much younger stage (E9.5) than the observed onset of CNP expression in the ventral part of spinal cord (data not shown and see below).
In contrast with embryonic spinal cord and postnatal CNS, Olig1 and Olig2 exhibited a different pattern in embryonic brain. As shown in Fig. 2H,I , Olig2 domains were broader than that of Olig1, and the sharp delineation of their limits corresponded to brain compartment boundaries. This contrasts with the observation by Lu et al. of no signi®cant differences between Olig1 and Olig2 expression domains in the rat embryonic brain. There were numerous Olig2-positive cells in the ventricular zone (VZ) and subventricular zone (SVZ) of the lateral (LGE) and medial (MGE) ganglionic eminences from E10.5 to E14.5, whereas few of these cells expressed Olig1 or CNP. This suggests that Olig2 expression is not limited to the oligodendrocyte lineage and thus may play a role distinct from Olig1 (Fig.   2J ). As many neurons are known to be generated in the VZ and SVZ of the GE at this stage , the expression pattern suggests that Olig2 is involved in some aspect of neurogenesis.
To examine further the role of Olig2 in neurogenesis, we made a polyclonal antibody against Olig2 and found that in rat E14.5, Olig2 domains roughly overlapped those of Mash1, sharing common boundaries (Fig. 3A,B ; Guillemot and Joyner, 1993) . Olig2 expression preceded that of Mash1 except for the pretectum where only Mash1 is expressed (data not shown). To con®rm Olig2 expression within the neuronal lineage, we performed double immunostaining with antibodies against Olig2 and an early post-mitotic immature neuron marker, TuJ1 (Lee et al., 1990) . Fig. 3C clearly shows that Olig2 was expressed in olfactory neurons at the basal side of the olfactory epithelium (OE) as well as in most of the progenitor cells in the ventral half of the rat E11.5 spinal cord (Fig. 3D) , which did not express TuJ1 (Fig. 3E) . At later stages, the broad Olig2 expression domain became dramatically restricted to the ventral ventricular region (Fig.  2F) , consistent with previous reports (Lu et al., 2000; Zhou et al., 2000) . The observation that Olig2 expression clearly precedes the generation of motor neurons and interneurons ( Fig. 3E ; Ericson et al., 1997) , and that oligodendrocyte progenitors later arise from the same domain as the motor neurons (Richardson et al., 1997) , strongly suggests that Olig2 is expressed in many types of neuronal progenitors including multipotential neuron/glia progenitors.
Experimental procedures

Cloning and sequencing of murine Olig genes
Identi®cation of human Olig1, Olig2 and Olig3 genes are described in Section 1. The mouse E19.5 cDNA library was purchased from Origene Inc. (Rockville, MD). PCR based cDNA screening for Olig1 and Olig3 was performed by manufacturer's protocol using primers speci®c to human Olig1 and Olig3 sequences. One clone was isolated in respective screenings. Mouse Olig2 was obtained as an EST clone (a kind gift from Drs S. Sugano and K. Hashimoto). The nucleotide sequences of the clones were determined on both strands using an ABI 377 autosequencer (PE Biosystems).
RNA blots and hybridization
Northern and dot blot membranes were purchased from Origene Inc. and Clontech, respectively. Radioactive DNA probes were prepared by random-primed labeling of following fragments; mouse Olig1 (EcoRI±BamHI fragment, 1.8 kb), mouse Olig2 (EcoRI±HindIII fragment, 1.8 kb), mouse Olig3 (SacI±HincII fragment, 956bp). Hybridization and washing were performed under high stringency conditions with standard protocols.
Genomic mapping
The mapping procedure is described elsewhere (Oyanagi et al., 1997) . Brie¯y, sets of primer pairs were designed to detect polymorphisms between C57BL/6J and MSM. With PCR using the primer pairs, 131 [(C57BL/6 £ MSM)F1 £ MSM] intersubspeci®c backcross mice were typed.
Animals
All animals used in this study were maintained and handled according to protocols approved by Kyoto University. C57BL/6J mice and Sprague±Dawley rats were purchased from CLER JAPAN, INC. (Tokyo). In all cases of mice and rat litters analyzed, the day of vaginal plug detection was considered 0.5 days post coitum (dpc).
Generation and puri®cation of polyclonal antibodies to Olig2 and Mash1
Peptides (MGASGAHPGDKLGC and CSAM-GAGTLPRLTSDAK) corresponding to the N-or C-terminal amino acid sequences of Olig2 and peptide (CDEGSYDPL-SPEEQELLDFTNWF) corresponding to the C-terminal amino acid sequence of Mash1 were generated with an additional cysteine to facilitate coupling. Peptides were coupled to keyhole limpet hemocyanin and injected into New Zealand White rabbits. Antibody puri®cation was performed with mixed peptides for Olig2 and single peptide for Mash1.
In situ hybridization and immunohistochemistry
For in situ hybridization (ISH) on 7 mm paraf®n sections of mouse tissues, we used a modi®cation of methods described by Hoshino et al. (1999) . Following ®xation in 4% paraformaldehyde, tissues were embedded in paraf®n, sectioned and put on APS-coated slides (Matsunami). After ISH staining, the sections were counterstained by nuclear fast red. For generating probes, the following fragments from mouse clones were cloned into pBluescript vectors (Stratagene): Olig1 (EcoRI±BamHI fragment, 1.8 kb), Olig2 (EcoRI±Asp718 fragment, 1.9 kb), CNP (XbaI± HindIII fragment, 394 bp). Digoxigenin-labeled singlestranded riboprobes were prepared by transcription of linearized plasmids using T7 or T3 RNA polymerase and DIG RNA labeling kit (Roche). The CNP probe used in this study does not distinguish two alternative splicing isoforms, CNP I and CNP II (Yu et al., 1994; Scherer et al., 1994) . Sense probes were used as controls.
For GFAP immunostaining after ISH, we ®rst performed standard ISH with mild proteinase K treatment. Anti-GFAP polyclonal antibody (Bio-Science Products AG, Switzerland) was used in conjunction with the VECSTAIN ABC staining kit (Vector) with diaminobenzidine (DAB) substrate.
The immunostaining of Olig2 and Mash1 was performed as described (Torii et al., 1999) . For double staining, TuJ1 mouse monoclonal antibody (BAbCO) was detected with anti-mouse IgG (Alexa Fluor 488-conjugated, green) and anti-Olig2 polyclonal antibody was detected with anti-rabbit IgG (Alexa Fluor 546-conjugated, red).
Database accession numbers
The GenBank accession numbers for the mouse sequences reported in this paper are Olig1 (AB038696), Olig2 (AB038697) and Olig3 (AB038698).
